Stay Updated with the Latest Hancock Jaffe Laboratories HJLI News in Real Time
Find HJLI news now at Meyka AI. Stay informed with the latest Hancock Jaffe Laboratories stocks updates, including price news, market analysis, and expert insights.
Hong Kong Public Housing Concrete Failures Expand to 4 Buildings in Tung Chung
Hong Kong Housing Authority finds concrete strength failures in 4 buildings at Tung Chung public housing project. Work halted on September 23 as independent lab tests underway.
Gina Rinehart Becomes Top Shareholder in Son’s Copper Explorer, September 17
Gina Rinehart’s Hancock Prospecting invests AU$8.7 million for 13.5% of White Cliff Minerals, overtaking her estranged son John Hancock as top shareholder. WCN stock surged 17.7% on the news.
White Cliff Minerals Surges 17.7% as Rinehart Invests A$8.7M
Gina Rinehart’s Hancock Prospecting invests A$8.7M in White Cliff Minerals, acquiring 13.5% stake. WCN shares surge 17.7% as copper explorer gains backing from Australia’s richest person.
White Cliff Minerals Surges 17.7% as Gina Rinehart Invests A$8.7M
White Cliff Minerals (WCN.AX) jumped 17.7% after Gina Rinehart’s Hancock Prospecting invested A$8.7M for a 13.5% stake. The deal funds exploration at the Rae copper project in Canada.
Egyptian TV Presenter Sarah Khalifa Sentenced to Death in Drug Trafficking Case
Egyptian TV presenter Sarah Khalifa, 39, sentenced to death by Cairo court for drug trafficking alongside 11 others. Court seized 750kg of narcotics. Verdict subject to appeal.
Moderna Tumbles 23.5% After 177% Surge on Cancer Vaccine Win, August 21
Moderna stock fell 23.5% to $133.32 on August 21 after surging 177% the prior day on its cancer vaccine breakthrough with Merck. RSI hit record 92.21, signaling extreme overbought conditions.
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.
Gina Rinehart’s $1.4B SpaceX Bet Signals Billionaire Confidence in Musk
Gina Rinehart, Australia’s richest person, holds 8 million SpaceX shares worth $1.4 billion, making it her largest US investment. Her US portfolio surged from $3.3 billion to $5.7 billion in six months.